GlaxoSmithKline Pharmaceuticals Limited Overview
Pro stress-test →GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. As one of the leading Indian pharma companies, GSK produces and markets pharmaceuticals for treatment of various diseases. The company operates through a comprehensive distribution network with manufacturing facilities and strong market presence across India.
Strategic Profile
Pro stress-test →Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. The company leverages a strong distribution and manufacturing infrastructure to serve diverse patient populations across India.
Competitive Landscape
Pro stress-test →GSK India competes in the Indian pharmaceutical market against major domestic players including Cipla, Lupin Pharmaceuticals, Aurobindo Pharma, and Sunpharma, as well as global multinational competitors. The market is characterized by intense competition on price and product efficacy across therapeutic categories.
Industry Context
GlaxoSmithKline Pharmaceuticals Limited operates in Pharmaceutical manufacturing and marketing.
Key facts
Founded: Subsidiary established post-2000 GSK merger · Headquarters: Mumbai, India · Employees: Not disclosed · Revenue: ₹3,822 crores (~$459M USD) · Market cap: ₹40,581 crores (~$4.9B USD)